Evidence map›Paper›PMID 42652251›Full record

ArticleBiomedicines2026

NTAN1 Promotes Glioblastoma Malignant Progression and Is a Novel Prognostic Factor of Poor Prognosis.

Jian Yang, Zihan Lin, Zhihan Wang, Shukai Lin, Minglei Chen, Hao Xu, Qi Lv, Li Gao, Jianwei Ge

Abstract read
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jian YangDepartment of Neurosurgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
Zihan LinState Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, College of Life Science and Technology, Guangxi University, Nanning 530004, China.ORCID 0009-0007-2740-8451
Zhihan WangDepartment of Neurosurgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gong Wei Road, Shanghai 201399, China.
Shukai LinDepartment of Neurosurgery, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya 572000, China.
Minglei ChenDepartment of Neurology, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya 572000, China.
Hao XuDepartment of Neurosurgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gong Wei Road, Shanghai 201399, China.
Qi LvDepartment of Medical Imaging, Shanghai Xuhui Central Hospital, 366 Longchuan North Road, Xuhui District, Shanghai 200237, China.
Li GaoDepartment of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.ORCID 0000-0002-3606-4837
Jianwei GeDepartment of Neurosurgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.

Funding

Joint Program on Health Science & Technology Innovation of Hainan Province WSJK2025MS207National Natural Science Foundation of China 82573088Natural Science Foundation of Shanghai 25ZR1402325project of Sanya Central Hospital (The Third People's Hospital of Hainan Province) SYZXYY202416Science and Technology Development Fund of Shanghai PudongNew Area PKJ2025-Y48Scientific Research Foundation provided by Pudong Hospital affiliated to Fudan University Yjzdzk2025-07
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glioblastomagrowthinvasiveNTAN1prognosis

Identifiers

PMID42652251
PMCPMC13509381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.